DECEMBER 6–10, 2022

Henry B. Gonzalez Convention Center


San Antonio, TX

Sermonix Pharmaceuticals

Sermonix Pharmaceuticals

Founded in late 2014 by David Portman, MD, a leading clinical researcher and expert in women’s health, menopause, and selective estrogen receptor modulators, Sermonix Pharmaceuticals is a privately held biotechnology company focused on the development and commercialization of targeted oncology products.
Booth Number